AU7810994A - Process for producing a virus-inactivated factor viii-containing fraction by chromatographic methods - Google Patents

Process for producing a virus-inactivated factor viii-containing fraction by chromatographic methods

Info

Publication number
AU7810994A
AU7810994A AU78109/94A AU7810994A AU7810994A AU 7810994 A AU7810994 A AU 7810994A AU 78109/94 A AU78109/94 A AU 78109/94A AU 7810994 A AU7810994 A AU 7810994A AU 7810994 A AU7810994 A AU 7810994A
Authority
AU
Australia
Prior art keywords
virus
producing
factor viii
chromatographic methods
containing fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU78109/94A
Other versions
AU687451B2 (en
Inventor
Djuro Josic
Monika Andrea Stadler
Ales Strancar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Octapharma AG
Original Assignee
Octapharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6501733&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU7810994(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma AG filed Critical Octapharma AG
Publication of AU7810994A publication Critical patent/AU7810994A/en
Application granted granted Critical
Publication of AU687451B2 publication Critical patent/AU687451B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A process for producing a virus-inactivated, factor VIII-containing fraction by chromatographic methods in which, starting with cryoprecipitate or blood plasma, possibly followed by a treatment with aluminium hydroxide, at least one separating operation is performed by membrane chromatography after the dissolution of the cryoprecipitate. The fractions are subjected to virus inactivation and preferably an additional pasteurisation step.
AU78109/94A 1993-11-04 1994-09-30 Process for producing a virus-inactivated factor VIII-containing fraction by chromatographic methods Expired AU687451B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4337573 1993-11-04
DE4337573A DE4337573C1 (en) 1993-11-04 1993-11-04 Process for the preparation of a virus-inactivated factor VIII-containing fraction by means of chromatographic methods
PCT/EP1994/003258 WO1995012609A1 (en) 1993-11-04 1994-09-30 Process for producing a virus-inactivated factor viii-containing fraction by chromatographic methods

Publications (2)

Publication Number Publication Date
AU7810994A true AU7810994A (en) 1995-05-23
AU687451B2 AU687451B2 (en) 1998-02-26

Family

ID=6501733

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78109/94A Expired AU687451B2 (en) 1993-11-04 1994-09-30 Process for producing a virus-inactivated factor VIII-containing fraction by chromatographic methods

Country Status (21)

Country Link
EP (1) EP0726907B1 (en)
JP (1) JP3739788B2 (en)
KR (1) KR960705841A (en)
CN (1) CN1109045C (en)
AT (1) ATE228533T1 (en)
AU (1) AU687451B2 (en)
CA (1) CA2175670C (en)
CZ (1) CZ290186B6 (en)
DE (2) DE4337573C1 (en)
ES (1) ES2182846T3 (en)
FI (1) FI116569B (en)
HU (1) HU222087B1 (en)
IL (1) IL111263A (en)
MY (1) MY113294A (en)
NO (1) NO317112B1 (en)
PL (1) PL181725B1 (en)
RU (1) RU2148411C1 (en)
SK (1) SK284215B6 (en)
UA (1) UA43855C2 (en)
WO (1) WO1995012609A1 (en)
ZA (1) ZA948667B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19618851C1 (en) * 1996-05-10 1997-07-24 Octapharma Ag Testing factor VIII containing preparations
EP0885394B1 (en) * 1996-03-08 2000-08-16 Octapharma AG Process for testing suitability of protein fractions containing factor viii
ES2137878B1 (en) * 1997-12-01 2000-10-01 Grifols Grupo Sa PROCEDURE FOR OBTAINING AN ATTENUATED HUMAN PLASMA OF VIRUSES FOR THERAPEUTIC USE.
WO2009156430A1 (en) * 2008-06-24 2009-12-30 Octapharma Ag A process of purifying coagulation factor viii
CA2821711C (en) 2010-12-15 2017-10-10 Baxter International Inc. Eluate collection using conductivity gradient

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
DE3432083A1 (en) * 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg PASTEURIZED, ISOAGGLUTININ-FREE FACTOR VIII PREPARATION AND METHOD FOR THE PRODUCTION THEREOF
US5043428A (en) * 1984-08-31 1991-08-27 Behringwerke Aktiengesellschaft Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
JPS62191042A (en) * 1986-02-17 1987-08-21 Kanegafuchi Chem Ind Co Ltd Blood coagulation factor viii adsorbent and method for purifying blood coagulation factor viii using same
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
US4774323A (en) * 1987-06-29 1988-09-27 Rorer Pharmaceutical Corporation Purification of von Willebrand Factor solutions using gel permeation chromatography
US4795806A (en) * 1987-07-16 1989-01-03 Miles Laboratories, Inc. Phospholipid affinity purification of Factor VIII:C
CA2001720C (en) * 1988-10-31 2001-10-02 Randal A. Goffe Membrane affinity apparatus and purification methods related thereto
ATE85221T1 (en) * 1988-11-05 1993-02-15 Octapharma Ag PROCESS FOR THE PREPARATION OF A HIGH PURITY, NON-INFECTIOUS ANTIHAEMOPHILIA FACTOR USING CHROMATOGRAPHY.
CH678155A5 (en) * 1989-08-09 1991-08-15 Fischer Ag Georg
AT399818B (en) * 1992-04-24 1995-07-25 Immuno Ag METHOD FOR PRODUCING A HIGH PURIFIED VIRUS-SAFE FACTOR VIII PREPARATION

Also Published As

Publication number Publication date
HU222087B1 (en) 2003-04-28
ES2182846T3 (en) 2003-03-16
NO317112B1 (en) 2004-08-16
CA2175670A1 (en) 1995-05-11
KR960705841A (en) 1996-11-08
CN1109045C (en) 2003-05-21
SK284215B6 (en) 2004-11-03
FI116569B (en) 2005-12-30
ATE228533T1 (en) 2002-12-15
IL111263A (en) 2000-07-16
WO1995012609A1 (en) 1995-05-11
EP0726907B1 (en) 2002-11-27
JP3739788B2 (en) 2006-01-25
SK56696A3 (en) 1996-10-02
UA43855C2 (en) 2002-01-15
CZ290186B6 (en) 2002-06-12
CA2175670C (en) 2005-08-02
PL314185A1 (en) 1996-09-02
AU687451B2 (en) 1998-02-26
MY113294A (en) 2002-01-31
PL181725B1 (en) 2001-09-28
DE4337573C1 (en) 1995-05-18
FI961900A0 (en) 1996-05-03
IL111263A0 (en) 1994-12-29
FI961900A (en) 1996-05-03
NO961816L (en) 1996-05-03
JPH09504532A (en) 1997-05-06
EP0726907A1 (en) 1996-08-21
NO961816D0 (en) 1996-05-03
CN1134157A (en) 1996-10-23
CZ118796A3 (en) 1996-12-11
HUT76530A (en) 1997-09-29
RU2148411C1 (en) 2000-05-10
DE59410213D1 (en) 2003-01-09
HU9601192D0 (en) 1996-06-28
ZA948667B (en) 1995-07-07

Similar Documents

Publication Publication Date Title
GR3003819T3 (en)
UA27732C2 (en) Process for preparation of a standardized human von willebrand factor concentrate and a concentrate prepared thereby
AU5596086A (en) Method of inactivating viruses involving adsorption on solid phase
DE69002395D1 (en) N-TERMINAL FRAGMENTS OF FUSION PROTEINS CONTAINING HUMAN SERUM ALBUMINE.
CA2030518A1 (en) Osteoinductive compositions
ES2051970T3 (en) PROCEDURE FOR THE PREPARATION OF A VERY PURE THROMBINE CONCENTRATE.
AU627618B2 (en) Process for preparing a concentrate of blood coagulation factor v111-von willebrand factor complex from total plasma
ES2068404T3 (en) A METHOD FOR ISOLATING THE FACTOR VIII.
AU687451B2 (en) Process for producing a virus-inactivated factor VIII-containing fraction by chromatographic methods
PT724600E (en) METHOD OF PREPARING A CONCENTRATE OF INTER-ALPHA-TRYPSIN INHIBITOR FOR THERAPEUTIC AND CONCENTRATED USE OBTAINED
ES2053684T3 (en) PROCEDURE TO PREPARE A HIGHLY PURE, NON-INFECTIOUS ANTIHEMOPHILIC FACTOR THROUGH CHROMATOGRAPHY.
CA2058948A1 (en) Processes for the recovery of naturally produced chymosin
GR3005036T3 (en)
ZA949820B (en) Process for preparing agents containing virus-inactivated vitamin k-dependent plasma components as well as protein C and protein S by membrane chromatography
ATE329602T1 (en) METHOD FOR PRODUCING PURIFIED TRANSFERRIN
ES2117197T3 (en) PROCEDURE FOR THE EXTRACTION AND PURIFICATION OF ALFA1-ANTI-TRYPSINE (ALFA1-PI) FROM THE COHN IV-1 FRACTION.
AU628145B2 (en) Substituted biphenyls
ES2123570T3 (en) USE OF THE LEUKOCYTE AND ENDOTHELIUM 1 ADHESION MOLECULA AND ANTIBODIES AGAINST IT IN THE TREATMENT OF ASTHMA.
EP0536564A3 (en) Method to purify streptolysin o, intact streptolysin o obtainable by this method and its use
UA13922A (en) Method for producing of contrinsulinic factor, blocking of insulin binding with its receptor and having of diabetogenic action
ES2094701B1 (en) PROCEDURE FOR THE PRODUCTION OF ANTITROMBINE III
TW345599B (en) Nonwoven barrier and method making the same
UA30651A (en) Method for obtaining of plasma protein components
GEP19950240B (en) Method for the Recovery of Harmonious Bioenergetic and Psychoemotional Balance in Human Body